Sirona Biochem Announces Positive Results With SBM-TFC-837 for Anti-Aging and Regenerative Medicine
Marketwired - Tue Mar 24, 7:02AM CDT
Sirona Biochem Corp. (TSX VENTURE: SBM) (FRANKFURT: ZSB) is pleased to announce that its French partner, Biogalenys, observed positive effects of Sirona's glycoprotein SBM-TFC-837 on human fibroblasts in preliminary, in vitro, studies in response to the stressed condition of ultraviolet (UV) radiation.
SBM.VN: 0.170 (+0.005)
Sirona Biochem to Present at BIO Asia 2015 and Received Over $1.1 Million of Warrants Exercised
Marketwired - Thu Mar 12, 1:49PM CDT
Sirona Biochem Corp. (TSX VENTURE: SBM) (FRANKFURT: ZSB) announces that its Chief Business Development Officer, Attila Hajdu, will be presenting at BIO Asia, March 24-25, 2015 in Tokyo, Japan. The Company's CSO, Dr. Geraldine Deliencourt-Godefroy, will also be attending.
SBM.VN: 0.170 (+0.005)
Sirona Biochem Announces Successful Development of a Third Skin Lightener With Superior Safety and Efficacy
Marketwired - Wed Mar 11, 3:00AM CDT
Sirona Biochem Corp. (TSX VENTURE: SBM) (FRANKFURT: ZSB) announces the successful development of a third innovative skin-lightening compound that has superior safety, with zero hydroquinone release and 8 times the efficacy of deoxyarbutin. This innovation was made possible through Sirona's platform technology of fluorination chemistry and through support of the European Union and the European Regional Development Fund (E.R.D.F.).
SBM.VN: 0.170 (+0.005)
Sirona Biochem to Present New Results at BIO Europe 2015
Marketwired - Wed Feb 18, 8:02AM CST
Sirona Biochem Corp. (TSX VENTURE: SBM) (FRANKFURT: ZSB) announces that its Chief Business Development Officer, Attila Hajdu, will be presenting at BIO Europe in Paris, France, on March 11th at 11:30AM GMT at the Paris Expo - Porte de Versailles.
SBM.VN: 0.170 (+0.005)
Sirona Biochem Invited to Present at Dose of the Valley Conference, San Francisco
Marketwired - Mon Jan 26, 8:02AM CST
Sirona Biochem Corp. (TSX VENTURE: SBM) (FRANKFURT: ZSB) announces that it has been chosen by the Consulate General of Canada to present at the Dose of the Valley conference on February 3-4 in San Francisco, California.
SBM.VN: 0.170 (+0.005)
Sirona Biochem's Subsidiary TFChem Awarded Prestigious French Innovation Trophy
Marketwired - Tue Dec 02, 6:45AM CST
Sirona Biochem Corp. (TSX VENTURE: SBM) (FRANKFURT: ZSB), announces that its subsidiary TFChem has been awarded the 6th Haute-Normandie Innovation Trophy from SEINARI -- the Region Haute-Normandie innovation agency. TFChem founder, and Sirona's Chief Scientific Officer, Dr. Géraldine Deliencourt-Godefroy, accepted the award at a ceremony held November 27th in Rouen, France.
SBM.VN: 0.170 (+0.005)
Sirona Biochem Names Attila Hajdu as Chief Business Development Officer
Marketwired - Mon Oct 27, 6:45AM CDT
Sirona Biochem Corp. (TSX VENTURE: SBM) (FRANKFURT: ZSB), announces that it has named Mr. Attila Hajdu as Chief Business Development Officer. Prior to joining Sirona Biochem, Attila held various senior leadership positions within GlaxoSmithKline (GSK) and Astellas Pharma, accumulating 17 years of experience in Sales, Marketing, R&D Finance, Medical Affairs and Business Development.
SBM.VN: 0.170 (+0.005), GSK: 48.23 (+0.51)
Sirona Biochem Announces Research Collaboration With Aegilops Applications
Marketwired - Mon Oct 20, 6:45AM CDT
Sirona Biochem Corp. (TSX VENTURE: SBM) (FRANKFURT: ZSB) today announced a collaboration with innovative French Company, Aegilops Applications. Aegilops specializes in the protection of plant seeds. The objective of the research collaboration is to develop a novel compound to improve germination and growth in plants, thereby enhancing crop production.
SBM.VN: 0.170 (+0.005)
Sirona Biochem: Obagi Medical Products Begins Manufacturing Scale-Up of Skin Lightening Agent
Marketwire - Tue Oct 07, 6:45AM CDT
Sirona Biochem Corp. (TSX VENTURE: SBM) (FRANKFURT: ZSB) is pleased to announce that its partner Obagi Medical Products Inc., a wholly-owned subsidiary of Valeant Pharmaceuticals International, Inc., has started manufacturing scale-up of the innovative skin lightening compound (TFC-849) originally developed by Sirona's scientists in France.
SBM.VN: 0.170 (+0.005), VRX: 207.50 (+1.78), VRX.TO: 261.09 (+2.06)
Sirona Biochem Launches Anti-Aging Preclinical Studies
Marketwire - Mon Sep 22, 6:45AM CDT
Sirona Biochem Corp. (TSX VENTURE: SBM) (FRANKFURT: ZSB) launches the next stage of development for its anti-aging compound library. With recent funding from Bpifrance (the French Public Investment Bank) and the district of Haute Normandie, Sirona Biochem's subsidiary TFChem (France) moves into the next phase of the agreement with the French laboratory Biogalenys.
SBM.VN: 0.170 (+0.005)